e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Pulmonary hypertension in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hepatopulmonary syndrome in non-cirrhotic patients with chronic viral hepatitis
Mahmoud Elhabashy (Minofeyia, Egypt), Mahmoud Elhabashy, Ahmed Khamis, Waleed Shehab, Mohamed Shaban, Abdallah Essa, Mahmoud Kamel
Source:
International Congress 2015 – Pulmonary hypertension in lung disease
Session:
Pulmonary hypertension in lung disease
Session type:
Thematic Poster Session
Number:
3758
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mahmoud Elhabashy (Minofeyia, Egypt), Mahmoud Elhabashy, Ahmed Khamis, Waleed Shehab, Mohamed Shaban, Abdallah Essa, Mahmoud Kamel. Hepatopulmonary syndrome in non-cirrhotic patients with chronic viral hepatitis. Eur Respir J 2015; 46: Suppl. 59, 3758
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Related content which might interest you:
Interstitial lung involvement in patients with chronic HCV hepatitis
Source: Eur Respir J 2006; 28: Suppl. 50, 744s
Year: 2006
Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019
Clinical experience with nintedanib for the treatment of IPF in 80 cases
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis
Source: Annual Congress 2007 - Tuberculosis
Year: 2007
Abnormal heart rate variability in patients with bronchiectasis
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
The metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Management of tuberculosis in patients with chronic liver dysfunction
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Pulmonary diseases in primary immunodeficiency syndromes
Source: Respipedia Article
Year: 2017
Sarcoidosis associated with interferon-α therapy for chronic hepatitis C
Source: Eur Respir J 2006; 28: Suppl. 50, 541s
Year: 2006
Interstitial lung disease caused by designer drugs
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015
Assessment of nutritional status in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
Hepatopulmonary syndrome in children with chronic liver disease
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005
Tuberculosis in patients with chronic renal failure
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006
Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Pulmonary gas exchange and vascular abnormalities in noncirrhotic chronic hepatitis
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007
Pulmonary function tests as predictors of mortality in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept